Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPROVE: Sintilimab + SBRT + Chemotherapy for CRLM
NCT06120127Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Sep 2023
- Primary completion
- Sep 2025
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in colorectal cancer (CRC), sponsored by Fudan University. Status: unknown.
02
Drugs
sintilimab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06120127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06120127.